Navigation Links
New findings offer more complete view of breast cancer gene mutations in US population

A large study funded by the National Institutes of Health today provided the clearest picture yet of the prevalence in the U.S. population of mutations in two genes associated with an increased risk of breast cancer. The genes are called Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2). In addition, the study identified key predictors for assessing which women are most likely to carry these genetic mutations.

Each year, approximately 200,000 women in the United States are diagnosed with breast cancer. The majority of breast cancer cases are caused by genetic changes that occur during a woman's lifetime and not by genetic mutations inherited from her parents. However, researchers estimate that inherited mutations play a role in anywhere from 5 to 27 percent of all breast cancer cases. In the mid 1990s, researchers found that mutations in the BRCA1 and BRCA2 genes are a major cause of the hereditary form of the disease. Women inheriting these mutations have a 40 to 85 percent lifetime risk of developing breast cancer, as well as an increased risk of ovarian cancer.

To date, most of the studies on BRCA1 and BRCA2 mutations have focused on families known to be at high risk for breast cancer and on women who develop breast cancer at a relatively young age. The new study, published today in the journal Cancer Research, looked at the prevalence and predictors of BRCA1 and BRCA2 mutations in under-studied groups of women, such as African Americans and older women.

"Studies of any notable size have focused almost exclusively on white women and young women. This research clearly was needed to improve our means of assessing the likelihood of carrying BRCA1 and BRCA2 mutations in a wider spectrum of women," said one of the study's lead investigators, Elaine Ostrander, Ph.D., chief of the Cancer Genetics Branch in the National Human Genome Research Institute's Division of Intramural Research. Dr. Ostrander was previously head of the genetics progra
'"/>

Source:NIH/National Human Genome Research Institute


Page: 1 2 3

Related biology news :

1. Surprising findings reported about iron overload
2. Study findings offer potential new targets for antibiotics
3. Oops! Researchers publish new findings on the brains response to costly mistakes
4. Biodiversity key to sustainable biofuel according to University of Minn. researchers findings
5. New stem-cell findings can help the body to cure itself
6. New findings could lead to vaccine for severe malaria
7. New findings blow a decade of assumptions out of the water
8. Ancient olfaction protein is shared by many bugs, offering new pest control target
9. Protein offers way to stop microscopic parasites in their tracks
10. Nanoparticles offer new hope for detection and treatment
11. Whats really making you sick? Plant pathologists offer the science behind Sick Building Syndrome
Post Your Comments:
(Date:12/14/2009)... or for Tasmanian devils biting each other ... the dinosaurs to extinction through the transmission of a ... Biology, highlights the ,paleobiological detective work, of David Varricchio ... to deduce that a protozoan parasite was to blame ... fossils. , The parasite,s modern-day equivalent, which infects birds, ...
(Date:12/14/2009)... A team of researchers from the Astrobiology Centre (INTA-CSIC) ... considered essential to the formation of the most basic ... blue. In order to carry out this study, published ... scientists recreated the chemical conditions of the early Earth. ... dissolved in ammoniac solutions it produces hydrogen cyanide, a ...
(Date:12/14/2009)... laparoscopy is in preventing some of the stresses of open ... blood flow and organ dysfunction. Laparoscopy is a type of ... , By adding another gas to the carbon ... at Duke University Medical Center have found they can preserve ... gas ethyl nitrite (ENO) helped to open blood vessels and ...
Breaking Biology News(10 mins):Prussian blue linked to the origin of life 2Gas improves blood flow and organ status during minimally invasive surgery 2Joint Committee on Judiciary Holds July 14 Hearing On Bill to Increase Criminal Penalties for Assaulting Nurses 51480 1Joint Committee on Judiciary Holds July 14 Hearing On Bill to Increase Criminal Penalties for Assaulting Nurses 51480 2Hologic to Present at the 29th Annual Canaccord Adams Global Growth Conference 51475 1Chinas Rheumatoid Arthritis Drug Market Will More than Double by 2013 51472 1Chinas Rheumatoid Arthritis Drug Market Will More than Double by 2013 51472 2Chinas Rheumatoid Arthritis Drug Market Will More than Double by 2013 51472 3
... findings appear to echo the insect worlds portrayed in the ... live in rigidly conformist societies. , Scientists from the Universities ... mathematical model to study the manner in which cooperative groups ... identifies that there are two scenarios in which a group ...
... Research Institute today announced that two researchers at Fred ... to be appointed HHMI Early Career Scientists. , ... Center,s Basic Sciences Division, and Toshiyasu Taniguchi, M.D., Ph.D., ... Public Health Sciences divisions, each will receive a six-year ...
... semipalmated sandpipers embark on their annual odyssey from the Canadian ... out on one of the world,s longest migrations. On the ... Fundy on the Canadian east coast, where they spend two ... have some of the highest levels of n-3 fatty acids ...
Other Biology News:Two Hutchinson Center researchers named HHMI Early Career Scientists 2Quails get super fit by simply eating omega-3 diet 2
(Date:12/11/2009)... SAN DIEGO, Dec. 11 Ambit Biosciences Corporation ... of Texas M. D. Anderson Cancer Center of the ... 220 Monotherapy E fficacy) Phase 2 ... myeloid leukemia (AML). AC220 is a novel, orally ... specifically designed as a FMS-like tyrosine kinase-3 (FLT3) inhibitor. ...
(Date:12/11/2009)... December 11, 2009 -- Esco announces the opening of a NEW ... as a technical service, training and logistics center to support Esco,s ... New Product Introductions (NPI) for temperature-controlled laboratory equipment. , ... ... opening of a NEW 2nd North American facility in Marietta, OH. ...
(Date:12/10/2009)... With the economy and markets exhibiting continued ... fastest-growing small cap equity research provider, will seek to ... within the micro cap market at the firm,s ... 2010 at the Grand Hyatt Hotel in New York, ... and undervalued by much of Wall Street, but the ...
(Date:12/10/2009)... 10 Vivakor, Inc. (OTC Bulletin ... entered into an exclusive, $5 million license ... Inc. ( www.regeneca.com ). The agreement ... a new cutting-edge nutraceutical formulation developed by ... future formulations by Vivakor for Regeneca. Under ...
Breaking Biology Technology:Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3
... refocusing of operations and workforce reduction, NEW ... KERX ) today announced that it is implementing ... rate and re-focus its,development efforts. The plan, which ... pivotal SUN-MICRO Phase 3 clinical trial of Sulonex(TM),(sulodexide) ...
... -- WuXi,PharmaTech (Cayman) Inc. (NYSE: WX ), ... development outsourcing,company with operations in China and the ... Chemistry CRO of the Year Award by the ... http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ), Dr. Richard Connell, ...
... Calif., and SINGAPORE, April 4, 2008 /PRNewswire/,-- Raven ... the,discovery and development of monoclonal antibody therapeutics (MAbs) ... announced a,collaboration to advance the discovery of novel ... the agreement, Raven will license its proprietary,whole cell ...
Other Biology Technology:Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan 2Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan 3Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan 4WX Crowned 'Chemistry CRO of the Year' by Pfizer 2Raven biotechnologies and Bioprocessing Technology Institute Announce Collaboration to Advance Discovery of Stem Cell Antibodies 2
These Costar 96-well, flat-bottom polystyrene EIA plates are used for EIAs, ELISAs, and other protein binding assays. Supplied as box of 100 (20 packages; 5 plates per package)....
... is a simple high performance method for ... detergents without significant dilution of protein solution. ... the Detergent-OUT Spin column and collect detergent ... for removing detergent from a maximum of ...
... The Chemicon Detergent-OUT Kit is a ... from protein solutions. Removes detergents without ... load the protein solution on the Detergent-OUT ... solution. The Med column is suitable ...
... are derived from frozen embedded tissue blocks, ... procedures to ensure the highest quality. Tissues ... one block, sectioned at a thickness of ... Sections are large (3-5 mm in diameter) ...
Biology Products: